Home
Lucira Health

Lucira Health Market Share Analysis for July 2026

lucira® by pfizer is the first covid-19 and flu test available over the counter that puts the power of the lab quality testing in your hands.

Health > Health - Other

Domainlucirahealth.com

Year Founded--

Employees51 - 200

Annual Revenue$25M - $50M

Lucira Health

Lucira Health (including company regionals)

lucirahealth.com

See more website traffic and engagement information

Lucira Health Revenue up to July 2026 is 25M - 50M

revenue generated by Lucira Health top domains

Lucira Health top domains revenue over 3 years

Revenue for Lucira Health top domains

lucirahealth.com25M - 50M

See more with Sales Intelligence

Total visits to Lucira Health's top domains

Understand Lucira Health market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Lucira Health's top domains

Analyze Lucira Health engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Lucira Health's top domains

See how Lucira Health keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Lucira Health top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Lucira Health

These are the website technologies, by industry, used by Lucira Health top domains

Advertising (14)

DoubleClick

Widget (5)

Twemoji

Content Management System (3)

WordPress

Marketing (3)

Google Marketing Platform

More Technologies

12

See all

News & Signals from Lucira Health

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPfizer Inc acquired Lucira Health, Inc. for $36.4M on Apr 1st '23.Lucira Health Inc (OTC: LHDXQ ) has been acquired by Pfizer Inc (NYSE: PFE ) for $36.4 million through a bankruptcy auction.

NewsLucira Health, Inc. launches at-home combination COVID-19 and flu test.Lucira today announced the US launch of its at-home combination COVID-19 and flu test, the first of its kind, following the February emergency use authorization (EUA) from the Food and Drug Administration (FDA).

NewsLucira Health, Inc. went public on Feb 1st '21.Lucira went public in February 2021 with a $159.9 million initial public offering.